Injective (INJ) has received a significant boost with the launch of regulated Injective Futures in the United States, marking a pivotal step in its institutional adoption. Listed on Bitnomial, a CFTC-regulated exchange, the product has driven a 20% surge in open interest (OI), signaling heightened market participation. Concurrently, INJ's price rallied over 10% in the past 24 hours, breaking through the $3.33 resistance level and currently trading near $3.45.
Regulated Futures: A Bridge for Institutional Capital
Injective Futures are CFTC-compliant derivatives traded on Bitnomial, a registered Designated Contract Market (DCM). This regulatory framework allows traditional financial institutions to access crypto derivatives with confidence. For Injective, the product not only attracts institutional liquidity but also strengthens its pricing authority within the DeFi ecosystem. The launch follows other innovations like the migration to native USDC and on-chain pre-IPO stocks, further expanding Injective's utility.
Soaring Open Interest and Price Action
Within 24 hours of the futures listing, open interest jumped by 20%, reflecting growing participation from both bulls and bears. The bullish side has been dominant, pushing INJ from $3.00 to break above $3.33 with strong volume. Technical indicators such as the MACD have flashed a bullish crossover, suggesting continued upward momentum.
Community Buyback Reduces Supply
Adding to the positive sentiment, the Injective community recently executed a buyback that removed 51,000 INJ from circulation. This supply reduction, combined with demand from futures trading, creates a favorable supply-demand dynamic. The buyback is part of Injective's governance mechanism to enhance token scarcity and reward long-term holders.
Next Target: $4.0 Psychological Level
With rising open interest and reduced supply, analysts see the $4.0 liquidity zone as the next major target. This level represents a critical psychological threshold. If INJ can break and hold above $4.0 with sustained volume, further upside is likely. However, traders should monitor profit-taking risks from increased OI and broader market volatility.
In summary, Injective's regulated futures launch, combined with supply cuts and rising participation, supports a bullish outlook. The coming days will be key to watch for sustained volume on Bitnomial and further ecosystem developments.